GPM Announces the Filing of a Securities Class Action on Behalf of Amicus Therapeutics, Inc. Investors

LOS ANGELES--(BUSINESS WIRE)-- Glancy Prongay & Murray LLP (“GPM”) announces the filing of a class action lawsuit in the United States District Court for the District of New Jersey, on behalf of investors of Amicus Therapeutics, Inc. ("Amicus" or the "Company") (NYSE: FOLD) who purchased shares between September 15, 2015 and October 1, 2015, both dates inclusive (the “Class Period”). Amicus investors have until December 7, 2015 to file a lead plaintiff motion, and investors are encouraged to contact GPM to discuss their legal rights.

On October 2, 2015, the Company disclosed that the FDA had “requested further integration of existing clinical data across studies” in connection with Amicus’s migalastat monotherapy treatment for Fabry disease, and that, “Amicus does not anticipate being in a position to submit the NDA for migalastat monotherapy in the United States by the end of this year.” On this news, the Company’s stock fell $7.36, or over 53%, to close at $6.39 on October 2, 2015, thereby injuring Amicus investors. The complaint alleges that Amicus misled investors regarding the Company’s prospects for FDA approval.

If you purchased Amicus securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at http://www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

About the Firm: Glancy Prongay & Murray LLP has represented investors, consumers and employees for 25 years. Based in Los Angeles with offices in New York City and Berkeley, the Firm has successfully prosecuted class action cases and complex litigation in federal and state courts throughout the country. As Lead Counsel or as a member of Plaintiffs’ Counsel Executive Committees, the Firm has recovered billions of dollars for parties wronged by corporate fraud and malfeasance.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151113005526/en/

Glancy Prongay & Murray LLP, Los Angeles
Lesley Portnoy, 310-201-9150 or 888-773-9224
[email protected]
www.glancylaw.com

Source: Glancy Prongay & Murray LLP

You May Also Be Interested In

• Completion of capital reduction in Spar Nord Bank A/S
• REBELXL - A Revolutionary Reformer Pilates Franchise Announce the Grand Opening of Its First Studio in Wyckoff, New Jersey
• Cohome Launches Innovative Fractional Ownership Marketplace to Transform Real Estate Investment for Retail Investors and Brokers